Board of Directors

Geoff is a Managing Director at HIG Capital, an alternative asset manager with $60 billion dollars under management. Geoff leads investments in provider services, payor services and healthcare technology for HIG’s Advantage Fund. Prior to HIG, Geoff worked in the private equity funds of Two Sigma, Lee Equity Partners, TPG Capital and Bain Capital and began his career as a consultant at Bain & Company. Geoff has been or is a director of several companies, including American Vision Partners, Community Medical Services, Circle of Care, Solaris Health, Summit BHC, Westfall Technik, Eating Recovery Centers, PDR Networks, Key Health, Paragon Industries, MassageLuXe and Aptalis Pharma. Geoff was a faculty lecturer at Stanford Business School and serves a Vice Chairperson of the Healthcare Private Equity Association. Geoff received an M.B.A. from Stanford Business School and a B.A. in Engineering Sciences cum laude from Dartmouth College.

Mr. O’Leary is a General Partner, having joined WCAS in 2015. Prior to joining WCAS, Mr. O’Leary worked at JLL Partners for over six years, focused primarily on healthcare investments. Earlier in his career, he worked in the Mergers and Acquisitions group at Merrill Lynch.

Mr. O’Leary received a B.A. from Washington and Lee University.

David Alpern is a Founding Partner, and the Managing Partner of Varsity Healthcare Partners. Prior to founding Varsity, Mr. Alpern was a Partner with Aurora Capital Group, a middle-market private equity firm, where he led the healthcare investing effort. Previously, Mr. Alpern was with GTCR Golder Rauner, a middle-market private equity investment firm, where he focused on both healthcare and financial services industries. Mr. Alpern began his career as an investment banking analyst in the global industrial & services group of Credit Suisse First Boston, where he focused on mergers and acquisitions and high yield financings. He holds a BA in History from the University of Michigan and an MBA from Harvard Business School.

Mr. Alpern serves on the Board of Directors for Orthopedic Care Partners, Emergency Care Partners, Ventra Health, Gastro Care Partners, Aspirion, United Aesthetics Alliance and VetEvolve.

Mr. DiGiovanni is an Investment Partner of Arsenal for the healthcare team. Prior to joining Arsenal in 2018, he was a Principal of Baird Capital for 10 years. Previously, Mr. DiGiovanni was an investment banking Analyst at Bank of America Merrill Lynch. He sits on the board of 3DR Labs, Hopebridge, Knowtion Health, MaxHealth and OncoHealth.

John received a B.A. from Michigan State University and an M.B.A. from Northwestern University Kellogg School of Management.  He received a Master of Public Policy from Harvard University.

Michael Farah has been involved in principal investing and investment banking since 2001. Prior to Linden, he was a Vice President at Metalmark Capital where he focused on healthcare investing. Mr. Farah began his career at UBS Investment Bank where he focused on M&A advisory and capital raising transactions for the healthcare sector and also spent three years with Summit Partners as a private equity associate.

Mr. Farah holds a Bachelor of Arts in Finance, with honors, from Carnegie Mellon University and an MBA from Harvard Business School.

Fazle Husain is Head of US Healthcare at CVC Capital Partners, a global private equity firm with a network of 23 offices and over 400 employees throughout Europe, Asia and US. The CVC Group manages over $50 billion of assets. Prior to joining CVC Capital, Fazle was a Managing Director at Metalmark Capital from 2007-2016, and was responsible for leading their effort in healthcare. Before Metalmark Capital, he was with Morgan Stanley & Co. in the private equity business, where he spent 18 years. He has a successful track record of investing in healthcare companies for over 25 years, including investments in the healthcare service, medical device, specialty pharmaceuticals and healthcare information technology sectors. He has invested in and served on the Boards of several private and public companies including ExamWorks, MedRisk, Icario, Allscripts (MDRX), Cross Country Healthcare (CCRN), The Medicines Company (MDCO), Cardiac Pathways (sold to Boston Scientific), Suros Surgical (sold to Hologic), Healthstream (HSTM), Cytyc Corp (sold to Hologic), Aegis Sciences, and Vanguard Healthcare Systems (sold to Tenet). He was the Chairman of the Board of Healogics (2008-2014), and was the Chairman of the Board of Collagen Matrix (2014-2016).

Mr. Husain received an Sc.B. degree in Chemical Engineering from Brown University, and an M.B.A. from Harvard Business School. He is on the Board of Advisors for The School of Engineering at Brown University. He lives in New York City, with his wife and three children.

Ms. Kim joined CD&R in 2008 and is a member of the Firm’s Inclusion Committee. She has played a key role in the Firm’s investments in Aster Insights (fka: M2GEN), Covetrus, Diversey, Gentiva, HD Supply, Inizio, naviHealth, ServiceMaster, and Sharp. Previously, she held positions at private equity firms Metalmark Capital and McCown De Leeuw & Co. and worked in the investment banking division of Goldman Sachs & Co. Ms. Kim has a J.D. from Harvard Law School, an M.B.A. from Harvard Business School, and a B.A. in economics and political science from Yale University.

Amr Kronfol joined Warburg Pincus in 2009. Based in New York, he focuses on investments in healthcare services and healthcare IT. Amr has been involved in the firm’s investments in Norstella, Ensemble, Aetion, Global Health Exchange, WebPT, Qualifacts, Modernizing Medicine, SummitHealth-CityMD, Alignment Healthcare, SOC Telemed, Helix, Silk Road Medical, Mercury Gate, GT Nexus, Multiview, and AmRest.

He is currently a board director of Norstella, WebPT, Ensemble Health, Qualifacts, Modernizing Medicine, and Helix. He is an observer at Global Health Exchange. Prior to joining Warburg Pincus, Amr worked in the fixed income division at Merrill Lynch where he structured and traded agency mortgage-backed securities. He graduated magna cum laude with a bachelor’s degree in Computer Science from Princeton University, and he was a Palmer Scholar at the Wharton School where he earned his MBA.

Ben joined Frazier Healthcare Partners in 2006. He represents Frazier on the boards of CSafe Global, Caravel Autism Health, Comprehensive Pharmacy Services, Matrix Medical Network, Parata Systems, SunMed and United Derm Partners. Ben has been responsible for Frazier’s successful investments in Ascension Orthopedics, DSI Renal, Golden State Medical Supply, Laboratory Supply Company and Northfield Medical.

Prior to Frazier, Ben was at Morgan Stanley Capital Partners (MSCP), focusing on investing in the healthcare sector. Before joining MSCP, he was in the Healthcare Investment Banking Group of Morgan Stanley.

Ben is also an Advisor for American Corporate Partners, a nationwide mentoring program dedicated to helping veterans transition to the private sector.

Ben received his M.B.A from the Tuck School of Business at Dartmouth and his B.B.A. in Finance and Computer Applications from the University of Notre Dame.

Church joined Kelso in 1998. For the preceding year, he was an Associate at Investcorp International, Inc. For the previous three years, he was an Analyst in the Corporate Finance group at BT Securities Corporation.

Church co-leads our healthcare practice and also focuses on investments in the business services and consumer sectors. He is currently a director of Elara Caring, Foundation Consumer Brands, and Valenz. He currently is active in the Firm’s investment in Individual FoodService.

Church received a B.A. in English, with a concentration in America Studies, from the University of Virginia in 1994. He is currently a member of the New York Regional Board of the College Foundation of the University of Virginia of the Arts and Sciences.

As Head of the Healthcare vertical and a member of the firm’s Management Committee, Josh manages a large and diverse portfolio and works closely with the Strategic Resource Group to drive growth for the firm’s portfolio companies. He also contributes thought leadership to THL’s Identified Sector Opportunity (ISO) platform and fosters a thriving culture through mentorship and professional development.

Josh is currently a Director of Adare Pharma Solutions, Agiliti Health, Inc., Autism Home Care Holdings, Inc., CSafe Global, Hospice Care, Intelligent Medical Objects, Professional Physical Therapy (ProPT), Senior Home Care Holdings, Inc. and Smile Doctors.

Before joining the THL team, Josh worked at J.P. Morgan Partners, McKinsey & Co. and The Beacon Group, LLC. In his spare time, he enjoys playing golf and cheering at his kid’s sports games. He lives outside of Boston with his superhuman wife and three active children.

John is a member of the Healthcare Sector team and the North America Regional team. He has been involved in a number of transactions, including Arxada (formerly Lonza Specialty Ingredients), Barentz, Medpace and National Seating & Mobility.

Prior to joining Cinven, John worked at Metalmark Capital where he co-led the Healthcare sector team. Before joining Metalmark, he worked at Citadel, Cressey & Company and Merrill Lynch.

John has an MBA from Harvard Business School and a BE in Biomedical Engineering from Vanderbilt University.

He joined Cinven in 2017.

Doug is a Managing Director with DW Healthcare Partners. His investment and transaction experience includes bio-analytical/immune-analytical service laboratories, institutional and specialty pharmacies, medical device manufacturers in the cardiac and orthopedic markets, physician practice management companies, elder care service providers and clinical research organizations.

Before joining DW Healthcare Partners, Doug worked for Bain & Company. While there, Doug led strategic due diligence efforts as part of Bain’s Private Equity Group. Prior to joining Bain’s Private Equity Group, Doug advised Bain’s commercial clients in the consumer products and food service industries.

Doug received a Bachelors degree from Cornell University and an MBA with Distinction from Harvard Business School, and previously sat on the Harvard Business School Alumni Board of Directors.

Prior to joining HEP 14 years ago, Dave was a Vice President for Susquehanna Growth Equity, a private equity group focused on growth stage technology companies. He was formerly the President and Chief Operating Officer of Onward Healthcare, Inc., a Welsh, Carson, Anderson & Stowe portfolio company. Prior to Onward, Dave was an Executive Vice President of Pinnacor, Inc., a General Atlantic portfolio company, which went public.

Dave is currently on the board of directors of Alivia Analytics, Catapult Health, Intraprise Health, Jet Health, NOCD, PatientIQ and Veterinary Innovative Partners. He is on the faculty at Columbia Business School. In addition, Dave is also a member of the Healthcare Initiative Advisory Board at Harvard Business School. Dave is a distinguished graduate of the United States Military Academy and holds an MBA from Harvard Business School.

Katherine Wood is a Partner with TPG Capital based in San Francisco, where she focuses on investments in the healthcare sector. She currently serves on the Boards of Convey Health Solutions, LifeStance Health and Ellodi, and was previously on the Boards of Adare, AskBio, and Neogene. She was also involved in TPG’s investments in Allogene, Aptalis, EnvisionRx, IASIS Healthcare, and Par Pharmaceutical and in founding TPG’s Women’s Affinity Group. She currently serves on the Board of Catalight, a non-profit healthcare organization.

Prior to joining TPG in 2009, Katherine worked in healthcare investment banking at Goldman, Sachs & Co. Katherine received a BS with Honors in molecular and cell biology from Stanford University, where she was on the varsity field hockey team, and an MBA with Distinction from Harvard Business School.